Deadline: 09-Feb-22
The North Carolina Biotechnology Center is seeking applications for the 2022 Translational Research Grant (TRG) Program to explore commercial applications or initiate the early commercial development of university-held life sciences inventions.
The technology must have the potential to solve a real-world problem as a commercial product in the life sciences sector.
Goals
The goals of the TRG program are:
- Transform basic research discoveries into product-focused translational research development
- Generate data that addresses important product development milestones, addresses the concerns of potential licensees or investors, or otherwise de-risks the technology for a specific commercial application
- Enable strategic “go/no-go” decision-making regarding further technology development and/or pursuit of intellectual property protection
- Enable technology licensing efforts by the university
- Establish goal-oriented partnerships between university scientists, product development professionals, and key stakeholders
Funding Information
- A maximum of $100,000 may be requested, with a $10,000 supplement available to engage the required project manager.
- Projects may last up to 18 months.
Eligibility Criteria
- Proposals may be submitted by any North Carolina university or non-profit research organization.
- Projects that appear to be subsidized R&D for any commercial entity may be administratively declined.
- Direct funding of R&D expenses for commercial firms, except contracted services, even if they have ties to NC-based universities and research institutions, is not consistent with the objectives of the program.
- At the time of submission, the Principal Investigator (PI) must hold a full-time, tenuretrack or tenured faculty appointment, or an appointment as full-time research faculty with a dedicated independent lab at the applicant institution, or an equivalent faculty designation in a medical/professional school.
- The PI may not have more than two active awards from the North Carolina Biotechnology Center at the same time.
-
Eligible projects support inventions that, at a minimum, have been disclosed to the university’s technology transfer office at the time of application.
-
The applicant must attest that the IP rights are assigned to the applicant’s institution and have not been committed through license or option to license to any third party at the time of application.
For more information, visit https://www.ncbiotech.org/funding/grants/translational-research-grant